Your browser doesn't support javascript.
loading
Early-Onset Dementia: Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers.
Konijnenberg, Elles; Fereshtehnejad, Seyed-Mohammad; Kate, Mara Ten; Eriksdotter, Maria; Scheltens, Philip; Johannsen, Peter; Waldemar, Gunhild; Visser, Pieter Jelle.
Afiliação
  • Konijnenberg E; *Alzheimer Center & Department of Neurology, VU University Medical Center, Amsterdam ∥Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands †Department of Neurobiology, Care Sciences, and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet ‡Department of Geriatric Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden §Department of Neurology, Danis
Alzheimer Dis Assoc Disord ; 31(2): 146-151, 2017.
Article em En | MEDLINE | ID: mdl-27158877
ABSTRACT

BACKGROUND:

Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.

METHODS:

We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ("SveDem", Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU University Medical Center).

RESULTS:

The frequency of EOD among all dementia patients was significantly lower in Copenhagen (410, 20%) and Stockholm (284, 21%) compared with Amsterdam (631, 48%). Not all quality indicator targets were met, such as the time to diagnosis, the mini-mental state examination score available, and the prescription of cholinesterase inhibitors. Cerebrospinal fluid sampling, registered in 2 sites, was performed in over 80% of the subjects.

CONCLUSIONS:

In tertiary referral centers in Copenhagen, Stockholm, and Amsterdam, quality indicators were not always met for patients with EOD. Results partly reflect differences in referral pattern, the application of diagnostic criteria, and local best practices. Standardized international procedures for patients with EOD may reduce this variability.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Colinesterase / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Guideline Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Alzheimer Dis Assoc Disord Assunto da revista: NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Colinesterase / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Guideline Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Alzheimer Dis Assoc Disord Assunto da revista: NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2017 Tipo de documento: Article